These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 6331652

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Changes in cyclic adenosine 3':5'-monophosphate-dependent protein kinases during the progression of urethan-induced mouse lung tumors.
    Butley MS, Stoner GD, Beer DG, Beer DS, Mason RJ, Malkinson AM.
    Cancer Res; 1985 Aug; 45(8):3677-85. PubMed ID: 2990675
    [Abstract] [Full Text] [Related]

  • 3. Appearance of 50,000- and 52,000-dalton cAMP receptor proteins in the nucleoli of regressing MCF-7 human breast cancer upon estrogen withdrawal.
    Kapoor CL, Grantham F, Cho-Chung YS.
    Cell Biol Int Rep; 1983 Nov; 7(11):937-46. PubMed ID: 6360384
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cyclic adenosine 3':5'-monophosphate receptor proteins in dysplastic and neoplastic human breast tissue cytosol and their inverse relationship with estrogen receptors.
    Handschin JC, Handloser K, Takahashi A, Eppenberger U.
    Cancer Res; 1983 Jun; 43(6):2947-54. PubMed ID: 6303571
    [Abstract] [Full Text] [Related]

  • 6. Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RI alpha 2 C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation.
    Levy FO, Rasmussen AM, Taskén K, Skålhegg BS, Huitfeldt HS, Funderud S, Smeland EB, Hansson V.
    Eur J Immunol; 1996 Jun; 26(6):1290-6. PubMed ID: 8647207
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Functional changes in the regulatory subunit of the type II cyclic adenosine 3':5'-monophosphate-dependent protein kinase isozyme during normal and neoplastic lung development.
    Butley MS, Beer DG, Malkinson AM.
    Cancer Res; 1984 Jun; 44(6):2689-97. PubMed ID: 6327022
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandin-E2-induced activation of adenosine 3'-5' cyclic monophosphate-dependent protein kinases of a murine macrophage-like cell line (P388D1).
    Yamamoto H, Suzuki T.
    J Immunol; 1987 Nov 15; 139(10):3416-21. PubMed ID: 2824605
    [Abstract] [Full Text] [Related]

  • 10. Differential regulation of oocyte maturation and cumulus expansion in the mouse oocyte-cumulus cell complex by site-selective analogs of cyclic adenosine monophosphate.
    Downs SM, Hunzicker-Dunn M.
    Dev Biol; 1995 Nov 15; 172(1):72-85. PubMed ID: 7589815
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
    Bodwin JS, Clair T, Cho-Chung YS.
    Cancer Res; 1978 Oct 15; 38(10):3410-3. PubMed ID: 210938
    [Abstract] [Full Text] [Related]

  • 14. Increase in type I cyclic adenosine 3':5'-monophosphate-dependent protein kinase activity and specific accumulation of type I regulatory subunits in adenovirus type 12-transformed cells.
    Ledinko N, Chan IJ.
    Cancer Res; 1984 Jun 15; 44(6):2622-7. PubMed ID: 6327020
    [Abstract] [Full Text] [Related]

  • 15. Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues.
    Tagliaferri P, Katsaros D, Clair T, Ally S, Tortora G, Neckers L, Rubalcava B, Parandoosh Z, Chang YA, Revankar GR.
    Cancer Res; 1988 Mar 15; 48(6):1642-50. PubMed ID: 2830966
    [Abstract] [Full Text] [Related]

  • 16. A study of cAMP binding proteins on intact and disrupted sperm cells using 8-azidoadenosine 3',5'-cyclic monophosphate.
    Schoff PK, Forrester IT, Haley BE, Atherton RW.
    J Cell Biochem; 1982 Mar 15; 19(1):1-15. PubMed ID: 6288746
    [Abstract] [Full Text] [Related]

  • 17. Comparison of soluble protein kinases from normal rat prostates and prostatic Dunning tumors.
    Chung LW, Breitweiser K.
    Cancer Res; 1983 Jul 15; 43(7):3297-304. PubMed ID: 6303579
    [Abstract] [Full Text] [Related]

  • 18. Mitotic apparatus and nucleoli compartmentalization of 50,000-dalton type II regulatory subunit of cAMP-dependent protein kinase in estrogen receptor negative MDA-MB-231 human breast cancer cells.
    Kapoor CL, Cho-Chung YS.
    Cell Biol Int Rep; 1983 Jan 15; 7(1):49-60. PubMed ID: 6299590
    [Abstract] [Full Text] [Related]

  • 19. Retinoylation of the type II cAMP-binding regulatory subunit of cAMP-dependent protein kinase is increased in psoriatic human fibroblasts.
    Tournier S, Raynaud F, Gerbaud P, Lohmann SM, Anderson WB, Evain-Brion D.
    J Cell Physiol; 1996 May 15; 167(2):196-203. PubMed ID: 8613459
    [Abstract] [Full Text] [Related]

  • 20. Correlation of estrogen receptors and charge alterations of regulatory subunits of cAMP-dependent protein kinases in human mammary tumor cells.
    Küng W, Fabbro D, Handloser K, Eppenberger U.
    Anticancer Res; 1984 May 15; 4(3):145-50. PubMed ID: 6465852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.